Efficiency and safety of desloratadine in combination with compound glycyrrhizin in the treatment of chronic urticaria: a meta-analysis and systematic review of randomised controlled trials

CONTEXT: Desloratadine, an H1 receptor antagonist, is suggested as an effective first-line drug for chronic urticarial (CU). However, the efficacy of desloratadine alone is limited, and the recurrence rate of CU is relatively high. OBJECTIVE: We sought to evaluate the efficacy and clinical feasibili...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Yulong, Tang, Yidan, Li, Miaoyue, Lai, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451672/
https://www.ncbi.nlm.nih.gov/pubmed/34517748
http://dx.doi.org/10.1080/13880209.2021.1973039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451672/
https://www.ncbi.nlm.nih.gov/pubmed/34517748
http://dx.doi.org/10.1080/13880209.2021.1973039

Ejemplares similares